Reporter

September 22, 2016

National Lymphedema Network honors VUMC research efforts

Lymphedema research conducted at Vanderbilt University Medical Center (VUMC) to better understand patient risk for this chronic condition and treatment responses received recognition at an international conference.

By Tom Wilemon
September 22, 2016

Effort set to help sickle cell patients manage meds

Vanderbilt University Medical Center is part of a 6-year, $4.4 million grant from the National Institutes of Health to improve the use of prescribed medication by sickle cell patients.

By VUMC News and Communications
September 22, 2016

Satellite clinic milestone

Members of the Vanderbilt Transplant Center staff celebrate with the 100th patient seen at the satellite pre-transplant clinic in Madison, Alabama, which opened in January.

By VUMC News and Communications
September 22, 2016

Neuroradiology’s Creasy takes part in South Africa training program

Jeffrey Creasy, M.D., chief of Neuroradiology in Vanderbilt’s Department of Radiology and Radiological Sciences, recently participated in a three-week American Society of Neuroradiology (ASNR) International Outreach Professorship to South Africa.

By VUMC News and Communications
September 22, 2016

New rates for Recreation and Wellness Center begin Jan. 1

As part of the VU/VUMC transition, all Medical Center employees and their families may continue to utilize the Recreation and Wellness Center for current membership rates through the end of 2016.

By VUMC News and Communications
September 22, 2016

Patient’s kidney transplant a ‘bittersweet’ family affair

Turning tragedy into triumph is something Khris Downing is learning to do. He’s getting a lot of practice, as he is alive today because of a life-saving organ donation from his older sister, Geraldine Williams, who died on July 26.

By Jessica Pasley
September 22, 2016

‘Shed-Meds’ to explore helping elderly reduce number of medications

Vanderbilt University Medical (VUMC) researchers have received a $2.9 million federal grant to test the effectiveness of a new intervention that aims to help older patients reduce the number of medications they may be taking on a regular basis.
By Kristin Smart
September 22, 2016

Hyundai Hope On Wheels grant spurs pediatric cancer research

Richard Ho, M.D., MSCI, associate professor of Pediatrics in the Division of Pediatric Hematology/Oncology, has been awarded a $250,000 Hyundai Hope On Wheels Scholar Grant to study ways to reduce long-term side effects of chemotherapy in pediatric cancer survivors and develop more personalized therapies for pediatric oncology patients.
By Christina Echegaray
September 22, 2016

H. pylori and anemia – new evidence

The bacterium Helicobacter pylori has been linked to anemia and may be contributing to the incidence and severity of anemia worldwide.
By Bill Snyder
September 19, 2016

Monroe Carell Jr. Children’s Hospital at Vanderbilt begins construction on four-floor expansion

Construction is underway at Monroe Carell Jr. Children’s Hospital at Vanderbilt for a planned four-floor expansion that will advance the size and scope of the hospital’s comprehensive array of specialty and subspecialty pediatric health care programs.
By Christina Echegaray
September 15, 2016

Study explores anti-viral potential of existing drugs

Emerging viral infections like Zika keep popping up around the world in such quick succession that medicine is having a hard time keeping up. It can take 15 years and more than a billion dollars to bring a new drug to market.
By Bill Snyder
September 15, 2016

Larger transplant centers produce improved outcomes: study

How many heart transplant programs do we really need? That was a question posed by a group of investigators, including Vanderbilt University Medical Center’s Ashish Shah, M.D., in a novel study that used a computerized algorithm to highlight the value of high-volume transplant centers with corresponding improved outcomes.
By Jessica Pasley
September 15, 2016

Researchers eye potential schizophrenia ‘switch’

Researchers at Vanderbilt University Medical Center have discovered a key mechanism that explains how compounds they’re developing can suppress schizophrenia-like symptoms without side effects in mice.
By Bill Snyder